Arctic Bioscience AS (OSL:ABS)
3.650
-0.500 (-12.05%)
Sep 12, 2025, 2:40 PM CET
Arctic Bioscience AS Revenue
Arctic Bioscience AS had revenue of 18.70M NOK in the half year ending June 30, 2025, a decrease of -2.02%. This brings the company's revenue in the last twelve months to 45.90M, up 43.97% year-over-year. In the year 2024, Arctic Bioscience AS had annual revenue of 44.40M with 31.55% growth.
Revenue (ttm)
45.90M
Revenue Growth
+43.97%
P/S Ratio
2.21
Revenue / Employee
2.09M
Employees
22
Market Cap
101.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 44.40M | 10.65M | 31.55% |
Dec 31, 2023 | 33.76M | -713.30K | -2.07% |
Dec 31, 2022 | 34.47M | 12.95M | 60.21% |
Dec 31, 2021 | 21.52M | 922.35K | 4.48% |
Dec 31, 2020 | 20.59M | -9.45M | -31.45% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 628.08M |
Nordhealth AS | 578.17M |
Photocure ASA | 522.86M |
ArcticZymes Technologies ASA | 104.33M |
Vistin Pharma ASA | 452.25M |
Omda AS | 458.96M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |